Resultados de la búsqueda 681-690 of 4182 for https://thanglongrobotics.com/

  1. Ensayos clínicos - Neurología

    Rochester, Minn. The purpose of this study is to collect blood samples for DNA analysis from patients clinically diagnosed with Alzheimers disease, Lewy Body ...

  2. Radiología - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to determine endothelial gene expression from guidewire biopsy during clinically indicated endovascular procedures.

  3. Radiología - Ensayos clínicos - Mayo Clinic

    Rochester, Minn. The purpose of this study is to investigate the value of ultrasound microvessel imaging for evaluation of transplant kidney health. Magnetic ...

  4. Ensayos clínicos - Neurología

    The purpose of this study is to investigate whether VNS therapy leads to any changes in the cognitive functions of individuals who have survived a stroke. A ...

  5. Oncología (médica) - Ensayos clínicos

    The purpose of this study is to monitor outcome to ensure that children and young adults with localized central nervous system (CNS) non-germinomatous germ ...

  6. Radiología - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to to determine the impact of anesthesia (liposomal bupivacaine) on diaphragm muscle forces using a non-invasive ultrasonographic ...

  7. Ensayos clínicos - Neurología

    The purpose of this study is to identify important physiologic trends in bedside ICU data such as cerebral perfusion pressure (CPP), intracranial pressure (ICP) ...

  8. Oncología (médica) - Ensayos clínicos

    This research study is being done to look at new MRI imaging guidance software, Philips Interventional iSuite software, to see if using will improve the ...

  9. Radiología - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to determine endothelial gene expression from guidewire biopsy during clinically indicated endovascular procedures. The genetic ...

  10. Radiología - Ensayos clínicos - Mayo Clinic

    ADPKD is a leading cause of end-stage renal disease. Recently, a new medication called Tolvaptan has been approved by the FDA to slow progression of ADPKD.